Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis.
We have previously demonstrated that a mixture of bradykinin and lysylbradykinin is generated in nasal secretions during the immediate allergic response to allergen. The present studies were performed to determine whether glandular kallikrein plays a role in kinin formation during the allergic reaction. Allergic individuals (n = 7) and nonallergic controls (n = 7) were challenged intranasally with appropriate allergen, and nasal lavages obtained before and after challenge were assayed for immunoreactive glandular kallikrein as well as for histamine, kinins, and N-alpha-tosyl-L-arginine methyl esterase (TAME-esterase) activity. The increase in postchallenge immunoreactive glandular kallikrein levels above baseline was significantly greater (p less than 0.01) for the allergic group (16.3 +/- 14 ng/ml; means +/- SD) than for the nonallergic controls (1.0 +/- 1.9 ng/ml). Increased levels of immunoreactive glandular kallikrein correlated with increases in kinins, histamine, and TAME-esterase activity and with the onset of clinical symptoms. Characterization of immunoreactive glandular kallikrein purified from postchallenge lavages by immunoaffinity chromatography confirmed the identity of this material as an authentic glandular kallikrein on the basis of its inhibition by protease inhibitors and by monospecific antibody to tissue kallikrein, its chromatographic behavior on gel filtration, and its ability to generate lysylbradykinin from highly purified human low m.w. kininogen. The specific activity of this purified material, in terms of kinin generation from kininogen, was very similar to that for authentic glandular kallikrein, suggesting that most if not all of the immunoreactive material purified from nasal lavages represented active enzyme. Inhibition studies by using pooled postchallenge lavages suggest that the majority of the kinin generating activity in these samples was due to glandular kallikrein. We conclude, therefore, that glandular kallikrein is secreted during the allergic response and can contribute to the formation of the lysylbradykinin produced during the allergic reaction.
D000293:Adolescent; D000328:Adult; D000485:Allergens / Q000008:administration & dosage; D002846:Chromatography, Affinity; D003429:Cross Reactions; D006801:Humans; D007106:Immune Sera; D007610:Kallikreins / Q000276:immunology / Q000302:isolation & purification / Q000378:metabolism*; D008875:Middle Aged; D008970:Molecular Weight; D009297:Nasal Mucosa / Q000201:enzymology / Q000378:metabolism*; D009299:Nasal Provocation Tests; D006255:Rhinitis, Allergic, Seasonal / Q000201:enzymology*; D020840:Tissue Kallikreins
D000485:Allergens; D007106:Immune Sera; D007610:Kallikreins; D020840:Tissue Kallikreins